Lenvatinib Plus PD-1 Inhibitors Versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma after the Failure of Sorafenib: A Retrospective Study
Therapeutics and Clinical Risk Management（2023）
关键词
hepatocellular carcinoma,lenvatinib,PD-1 inhibitors,regorafenib,sorafenib,overall survival
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要